Last reviewed · How we verify
NCT06368206
Recording of Physiological Data Via an Optical Sensor At the Fingertip Alongside with Double Auscultatory and Pulse Oximetry to Evaluate the Effectiveness of an Optical Blood Pressure Monitoring (OBPM)
NA trial testing Investigational device Aktiia G2C in Hypertension in 85 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Aktiia SA |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 85 |
| Start date | 25 June 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Investigational device Aktiia G2C
- Marketed device used as reference for blood pressure monitoring: double auscultation cuff
- Marketed device used as comparative device for blood pressure and pulse rate monitoring: Aktiia Bracelet G2
- Marketed device used as comparative device for blood pressure and pulse rate monitoring: oscillometric upper-arm cuff
- Marketed device used as comparative device for blood pressure and pulse rate monitoring: oscillometric wrist cuff
- Marketed device used as reference for pulse rate monitoring: pulse finger oximeter
Conditions studied
- Hypertension — all drugs for Hypertension →
Sponsor
Aktiia SA
Who can join
Adults 21 to 85, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study, OBPM\_Calfree2024, with N = 85 participants minimum over 1 visit (lasting around 1h), has been designed to collect raw optical data with Aktiia.product-G2C Clinical investigational system together with several reference systems within a cohort of subjects characterized by a wide variety of phenotypes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of two validated oscillometric devices in a home-like setup reveals pronounced blood pressure differences and reduced precision.
Zahnd J, Thompson B, Rigon PA, Taffé P, et al · · 2026 · PMID 41514019 · DOI 10.1038/s41440-025-02514-3
Verify or expand the search:
- PubMed search for NCT06368206
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Aktiia SA trials
Trials by the same sponsor.
- NCT07507903 — OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device · NA · not yet recruiting
- NCT07099716 — OBPM_HARMONY: Physiological Data Recording Over 24 Hours Using the Continual Optical Hilo Blood Pressure Monitor and an · not yet recruiting
- NCT06670677 — Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Predi · recruiting
- NCT06698536 — OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, · NA · recruiting
- NCT05746117 — Continual vs. Routine Home Blood Pressure Monitoring and Management in Diverse Community Practice: CHANGE-BP · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06368206 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aktiia SA
- Last refreshed: 17 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06368206.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing